Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients.
Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients.
复制标题
DOI:
10.7326/0003-4819-153-7-201010050-00005
复制
发表时间:
2010-10-05
影响因子:
39.2
通讯作者:
PREDICT (Personalized Risk Evaluation and Diagnosis in the Coronary Tree) Investigators
中科院分区:
文献类型:
--
作者:
Rosenberg S;Elashoff MR;Beineke P;Daniels SE;Wingrove JA;Tingley WG;Sager PT;Sehnert AJ;Yau M;Kraus WE;Newby LK;Schwartz RS;Voros S;Ellis SG;Tahirkheli N;Waksman R;McPherson J;Lansky A;Winn ME;Schork NJ;Topol EJ;PREDICT (Personalized Risk Evaluation and Diagnosis in the Coronary Tree) Investigators
Diagnosis of significant coronary artery disease (CAD) in at risk patients can be challenging, typically including non-invasive imaging modalities and ultimately the gold standard of coronary angiography. Previous studies suggested that peripheral blood gene expression can reflect the presence of CAD. To validate a previously developed 23-gene expression-based classifier for diagnosis of obstructive CAD in non-diabetic patients. Multi-center prospective trial with blood samples drawn prior to coronary angiography. Thirty-nine US centers. An independent validation cohort of 526 non-diabetic patients clinically-indicated for coronary angiography None. Receiver-operator characteristics (ROC) analysis of classifier score measured by real-time polymerase chain reaction (RT-PCR), additivity to clinical factors, and reclassification of patient disease likelihood vs disease status defined by quantitative coronary angiography (QCA). Obstructive CAD defined as ≥50% stenosis in ≥1 major coronary artery by QCA. The overall ROC curve area (AUC) was 0.70 ±0.02, (p<0.001); the classifier added to clinical variables (Diamond-Forrester method) (AUC 0.72 with classifier vs 0.66 without, p = 0.003). Net reclassification was improved by the classifier over Diamond-Forrester and an expanded clinical model (both p<0.001). At a score threshold corresponding to 20% obstructive CAD likelihood (14.75), the sensitivity and specificity were 85% and 43%, yielding NPV of 83% and PPV 46%, with 33% of patient scores below this threshold. The study excluded patients with chronic inflammatory disorders, elevated white blood counts or cardiac protein markers, and diabetes. This non-invasive whole blood test, based on gene expression and demographics, may be useful for assessment of obstructive CAD in non-diabetic patients without known CAD. CardioDx, Inc.
登录
查看更多内容
影响因子:
39.2
作者:
Cook NR;Ridker PM
通讯作者:
Ridker PM
影响因子:
4.6
作者:
Ardigo, Diego;Assimes, Themistocles L.;Quertermous, Thomas
通讯作者:
Quertermous, Thomas
影响因子:
37.8
作者:
CHAITMAN, BR;BOURASSA, MG;KILLIP, T
通讯作者:
KILLIP, T
影响因子:
4.4
作者:
Palmer, Chana;Diehn, Maximilian;Alizadeh, Ash A;Brown, Patrick O
通讯作者:
Brown, Patrick O
影响因子:
37.8
作者:
Ridker PM;Paynter NP;Rifai N;Gaziano JM;Cook NR
通讯作者:
Cook NR